血糖管理团队联合IBGMS对住院患者高血糖质量控制状况的影响研究

发布时间：2018-10-16 17:16

【摘要】：目的:研究血糖管理团队联合互联网血糖监测系统(IBGMS)对住院患者高血糖质量控制状况的影响,为进一步优化住院患者高血糖质量控制模式提供方案。方法:收集某三甲医院血糖管理团队联合IBGMS高血糖质量控制模式建立前2015年6月1日至6月30日和血糖管理团队联合IBGMS高血糖质量控制模式建立后2016年6月1日至6月30日收住入院的非内分泌科符合本研究纳入及排除标准的住院高血糖患者,其中建立后536例,建立前332例。采用前后对照的研究方法比较各观察指标。具体指标比较采用统计学方法,各组间均数的比较采用两独立样本t检验,率的比较采用χ2检验,以P0.05为差异有显著性。结果:由于血糖管理团队联合IBGMS的建立,建立后高血糖检出率(28.62%)较建立前高血糖检出率(16.8%)升高(P0.001),建立后Hb A1c检测率(92.91%)较建立前Hb A1c检测率(90.66%)无明显差异(P=0.234),建立后高血糖监测率(98.88%)、高血糖治疗率(74.81%)、目标血糖达标率(40.11%)较建立前高血糖监测率(74.40%)、高血糖治疗率(54.21%)、目标血糖达标率(28.61%)均升高(P0.001、P0.001、P=0.001),建立后行OGTT率(27.31%)较建立前行OGTT率(34.68%)无明显差异(P=0.117),建立后新诊断糖代谢异常率(21.30%)较建立前新诊断糖代谢异常率(9.25%)升高(P=0.001),建立后平均血糖监测次数(47.57±26.619)较建立前平均血糖监测次数(31.92±25.350)升高(P0.001),建立后低血糖发生率(5.97%)较建立前低血糖发生率(9.94%)降低(P=0.031),建立后平均住院日(9.95±2.801)d较建立前平均住院日(11.36±3.012)d缩短(P0.001)。结论:建立血糖管理团队联合IBGMS的高血糖质量控制模式可有效改善住院患者高血糖质量控制状况。
[Abstract]:Objective: to study the effect of blood glucose management team and (IBGMS) on the quality control of hyperglycemia in hospitalized patients, and to provide a scheme for optimizing the quality control mode of hyperglycemia in hospitalized patients. Methods: blood glucose management team and IBGMS hyperglycemia quality control model were collected from a third class hospital from June 1 to June 30, 2015 and from June 1 to June 30, 2016 after the establishment of blood glucose management team and IBGMS hyperglycemia quality control model. The non-endocrine department admitted to hospital as of June 30 met the criteria for inclusion and exclusion of hyperglycemia in the study. There were 536 cases after establishment and 332 cases before establishment. The observation indexes were compared by using the control method before and after. Statistical method was used to compare the specific indicators, two independent samples t test was used to compare the mean of each group, and 蠂 2 test was used to compare the rate, with P0.05 as the significant difference. Results: due to the establishment of blood glucose management team and IBGMS, The detection rate of hyperglycemia after establishment (28.62%) was higher than that before establishment (16.8%) (P0.001). The detection rate of Hb A1c after establishment (92.91%) was not significantly different from that of Hb A1c (90.66%) before establishment (P0. 234), the monitoring rate of hyperglycemia after establishment (98.88%), the treatment rate of hyperglycemia (74.81%), and the target blood glucose detection rate (74.81%). The rate of reaching the standard (40.11%) was higher than that before establishment (74.40%), the rate of hyperglycemia treatment (54.21%) and the target rate of blood glucose (28.61%) were increased (P 0.001%, P 0.001%). The rate of OGTT after establishment (27.31%) was not significantly different from that before establishment (34.68%), and the rate of abnormal glucose metabolism after establishment (21.30%) was higher than that before establishment (P < 0.05). The rate of newly diagnosed abnormal glucose metabolism was increased (9.25%) before establishment (P0. 001). The average blood glucose monitoring times after establishment (47. 57 卤26.619) were higher than those before establishment (31. 92 卤25.350) (P0. 001). The incidence of hypoglycemia after establishment (5. 97%) was lower than that before establishment (9. 94%) (P0. 031). The average hospitalization days (9.95 卤2.801) days were shorter than those before establishment (11.36 卤3.012) days (P0.001). Conclusion: the establishment of hyperglycemia quality control model combined with IBGMS can effectively improve the hyperglycemia quality control of inpatients.
【学位授予单位】：遵义医学院
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：R587.1

【相似文献】